Fortrea (NASDAQ:FTRE) Shares Gap Down – What’s Next?

Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) gapped down prior to trading on Thursday. The stock had previously closed at $25.88, but opened at $23.63. Fortrea shares last traded at $22.6190, with a volume of 372,720 shares changing hands.

Key Fortrea News

Here are the key news stories impacting Fortrea this week:

• Positive Sentiment: Fortrea reported third-quarter adjusted earnings of $0.28 per share, above the $0.22 consensus estimate and up from $0.12 a year earlier. Revenue of $691.5 million also exceeded expectations of $671.6 million. Fortrea Q3 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management forecast 2026 revenue of $2.665 billion to $2.690 billion and raised its adjusted EBITDA outlook to $210 million-$218 million, signaling improved expected operating profitability. Fortrea Raises Adjusted EBITDA Outlook
• Positive Sentiment: Barclays raised its price target from $23 to $26 and maintained an “overweight” rating, reflecting increased confidence in Fortrea’s valuation and earnings potential. Barclays Fortrea Rating
• Neutral Sentiment: Despite the earnings beat, Fortrea continues to report a negative net margin, so investors may remain focused on whether the improved EBITDA outlook translates into sustainable bottom-line earnings. Fortrea Third-Quarter Results
• Negative Sentiment: Fortrea shares fell after the results, indicating that investors may have viewed the revised guidance, business outlook, or earnings quality as less compelling than the headline quarterly beat. Fortrea Shares Drop After Q3 Results

Wall Street Analyst Weigh In

Several analysts have recently weighed in on FTRE shares. TD Cowen lifted their target price on shares of Fortrea from $19.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, August 4th. William Blair raised shares of Fortrea to a “hold” rating in a research report on Wednesday, July 29th. Jefferies Financial Group restated a “hold” rating and set a $21.50 price target on shares of Fortrea in a research note on Friday. Citigroup lifted their price objective on Fortrea from $22.00 to $27.00 and gave the company a “buy” rating in a report on Friday. Finally, Mizuho lifted their price objective on Fortrea from $13.00 to $16.00 and gave the company a “neutral” rating in a report on Monday, July 13th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Fortrea currently has an average rating of “Hold” and a consensus price target of $23.68.

Fortrea Trading Down 8.0%

The company has a quick ratio of 0.96, a current ratio of 0.97 and a debt-to-equity ratio of 1.94. The business’s fifty day moving average is $20.28 and its two-hundred day moving average is $15.74. The firm has a market cap of $2.02 billion, a price-to-earnings ratio of -29.16, a price-to-earnings-growth ratio of 0.56 and a beta of 1.93.

Fortrea (NASDAQ:FTRE) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.06. The firm had revenue of $691.50 million for the quarter, compared to the consensus estimate of $671.57 million. Fortrea had a positive return on equity of 13.98% and a negative net margin of 2.58%. Equities analysts anticipate that Fortrea Holdings Inc. will post 0.86 earnings per share for the current fiscal year.

Insider Activity at Fortrea

In other news, CEO Anshul Thakral sold 99,869 shares of the company’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $19.16, for a total value of $1,913,490.04. Following the completion of the sale, the chief executive officer directly owned 316,797 shares of the company’s stock, valued at $6,069,830.52. This represents a 23.97% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.73% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of FTRE. WINTON GROUP Ltd boosted its position in shares of Fortrea by 26.7% during the second quarter. WINTON GROUP Ltd now owns 389,155 shares of the company’s stock worth $6,771,000 after buying an additional 82,059 shares during the period. Eagle Health Investments LP raised its position in Fortrea by 7.3% in the 1st quarter. Eagle Health Investments LP now owns 1,307,560 shares of the company’s stock valued at $12,317,000 after buying an additional 89,000 shares during the last quarter. Assenagon Asset Management S.A. raised its position in Fortrea by 90.7% in the 2nd quarter. Assenagon Asset Management S.A. now owns 173,129 shares of the company’s stock valued at $3,012,000 after buying an additional 82,349 shares during the last quarter. Wellington Management Group LLP bought a new stake in Fortrea in the 2nd quarter valued at approximately $41,488,000. Finally, Hillsdale Investment Management Inc. bought a new stake in Fortrea in the 1st quarter valued at approximately $2,990,000.

About Fortrea

Fortrea Holdings Inc is a global contract research organization (CRO) that provides services to pharmaceutical, biotechnology and medical device companies. The company helps clients plan, manage and execute clinical development programs, supporting the testing of new medicines and therapies from early-stage research through regulatory approval and post-approval activities.

Its services include Phase I through Phase IV clinical trials, clinical operations, patient recruitment and access, data management, biostatistics, medical monitoring, pharmacovigilance and regulatory support.